Used in immunological research to quantify levels of CXCR3, a receptor involved in T-cell and immune cell migration, this ELISA kit enables scientists to study inflammatory diseases, autoimmune disorders, and cancer progression. It is particularly valuable in assessing immune responses in conditions like multiple sclerosis, rheumatoid arthritis, and psoriasis. Researchers also use it to evaluate the effectiveness of therapeutic agents targeting chemokine signaling pathways. The kit supports drug development and biomarker validation by providing a reliable method to measure CXCR3 expression in cell cultures, serum, or plasma samples.